Laxminarayan, Ramanan
Ramanan Laxminarayan
VIAF ID: 38917134 (Personal)
Permalink: http://viaf.org/viaf/38917134
Preferred Forms
-
- 100 1 _ ‡a Laxminarayan, Ramanan
- 100 1 _ ‡a Laxminarayan, Ramanan
-
-
-
-
-
- 100 1 _ ‡a Laxminarayan, Ramanan
-
- 100 1 _ ‡a Laxminarayan, Ramanan
- 100 1 _ ‡a Laxminarayan, Ramanan
- 100 0 _ ‡a Ramanan Laxminarayan
4xx's: Alternate Name Forms (2)
5xx's: Related Names (1)
- 510 2 _ ‡a Center for Disease Dynamics, Economics & Policy ‡g Washington, DC ‡e Affiliation
Works
Title | Sources |
---|---|
Battling resistance to antibiotics and pesticides : an economic approach | |
Choosing health : an entitlement for all Indians | |
Extending the cure : policy responses to the growing threat of antibiotic resistance | |
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later | |
Mental, neurological, and substance use disorders | |
The mortality burden of multidrug-resistant pathogens in India: a retrospective observational study | |
The need for better evidence to evaluate the health & economic benefits of India's Rashtriya Swasthya Bima Yojana. | |
On the implications of endogenous resistance to medications. | |
On the importance of incentives in hospital infection control spending. | |
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections | |
Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016. | |
Pooling RT-PCR or NGS samples has the potential to cost-effectively generate estimates of COVID-19 prevalence in resource limited environments | |
Postgraduate education in nutrition in south Asia: a huge mismatch between investments and needs | |
Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study | |
The potential global gains in health and revenue from increased taxation of tobacco, alcohol and sugar-sweetened beverages: a modelling analysis | |
Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India. | |
Poverty and prevalence of antimicrobial resistance in invasive isolates | |
Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis | |
The Prevalence of Extended-Spectrum Beta-Lactamase-Producing Multidrug-Resistant Escherichia Coli in Poultry Chickens and Variation According to Farming Practices in Punjab, India | |
Public health. From financing to fevers: lessons of an antimalarial subsidy program | |
The quadruple burden of sepsis. | |
Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods | |
Quantifying uncertainty in intervention effectiveness with structured expert judgement: an application to obstetric fistula | |
Ramanan Laxminarayan: Khủng hoảng sắp tới của thuốc kháng sinh | |
Ramanan Laxminarayan: Nadchodzący kryzys antybiotykowy | |
Ramanan Laxminarayan: The coming crisis in antibiotics | |
Reduced burden of childhood diarrheal diseases through increased access to water and sanitation in India: A modeling analysis. | |
Reducing stunting in India: what investments are needed? | |
Reinvesting in health post-2015. | |
Relationship between early-life nutrition and ages at menarche and first pregnancy, and childbirth rates of young adults: Evidence from APCAPS in India | |
Reply to Abat et al.: Improved policies necessary to ensure an effective future for antibiotics | |
Reply to Author. | |
Reply to Charra et al.: Global longitudinal assessment of 2019 changes in defined daily doses | |
Reply to Chopra and Rizvi | |
Reproductive, maternal, newborn, and child health | |
Resistance movement: Hospital administrators must join the fight against antibiotic overuse | |
Respiratory fluoroquinolone use and influenza | |
Response | |
Risks to Children under-five in India from COVID-19 | |
Seasonal and temperature-associated increases in gram-negative bacterial bloodstream infections among hospitalized patients | |
Seasonality and temporal correlation between community antibiotic use and resistance in the United States. | |
Self-enforcing regional vaccination agreements | |
Sequential development and exploitation of an exhaustible resource: do monopoly rights promote conservation? | |
Should New Antimalarial Drugs Be Subsidized? | |
Simulating the impact of excise taxation for disease prevention in low-income and middle-income countries: an application to South Africa. | |
The Socioeconomic and Institutional Determinants of Participation in India's Health Insurance Scheme for the Poor | |
Strategic interactions in multi-institutional epidemics of antibiotic resistance | |
Superinfection and the evolution of resistance to antimalarial drugs. | |
Surveillance of antimicrobial consumption in animal production sectors of low- and middle-income countries: Optimizing use and addressing antimicrobial resistance. | |
Synthesizing epidemiological and economic optima for control of immunizing infections | |
Tobacco initiation, cessation, and change: evidence from Vietnam. | |
Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index | |
Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008-2014. | |
Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012 | |
Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010 | |
Twitter to engage, educate, and advocate for global antibiotic stewardship and antimicrobial resistance | |
Unit cost of medical services at different hospitals in India | |
Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition | |
Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis | |
The unsurprising story of MDR-TB resistance in India | |
Use antimicrobials wisely | |
Using oral vancomycin prescriptions as a proxy measure for Clostridium difficile infections: a spatial and time series analysis | |
Vaccination coverage in India: a small area estimation approach. | |
Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease? | |
The value of information : methodological frontiers and new applications in environment and health | |
The value of tracking antibiotic consumption | |
Valuing vaccines using value of statistical life measures | |
Variation in cost and performance of routine immunisation service delivery in India. | |
Who is at the highest risk from COVID-19 in India? Analysis of health, healthcare access, and socioeconomic indicators at the district level | |
Will a global subsidy of artemisinin-based combination treatment (ACTs) for malaria delay the emergence of resistance and save lives?, 2005: | |
Раманан Лакшминараян: Грядущий кризис антибиотиков | |
প্রত্যুত্তর | |
라마난 락스미나라얀 (Ramanan Laxminarayan): 다가오는 항생제의 위기 | |
ラマナン・ラクシュミーナラヤン: 迫り来る抗生物質の危機 |